Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
99.78
Aug 06 • 5:58 AM ET Dollar change+0.66 Percentage change(0.67%)
Aug 05, 11:33 AMCVS Health beats Q2 estimates, raises 2026 EPS and cash flow guidance, pre-guides 2027 amid PBM headwinds
Index
S&P 500
Market Cap
127.31B
Enterprise Value
194.02B
Income
2.93B
Sales
407.94B
Book/sh
60.85
Cash/sh
9.26
Employees
300000
IPO
Oct 01, 1952
P/E
43.82
Forward P/E
11.80
PEG
0.92
P/S
0.31
P/B
1.64
P/C
10.77
P/FCF
17.22
EV/EBITDA
10.86
EV/Sales
0.48
Quick Ratio
0.66
Current Ratio
0.87
Debt/Eq
1.01
LT Debt/Eq
0.95
Option/Short
Yes / Yes
EPS (ttm)
2.28
EPS next Y
8.46
EPS next Q
1.68
EPS this Y
13.35%
EPS next Y
10.52%
EPS next 5Y
12.85%
EPS past 3/5Y
-24.70% -23.94%
Sales past 3/5Y
7.60% 8.40%
EPS Y/Y TTM
-45.09%
Sales Y/Y TTM
7.68%
EPS Q/Q
63.49%
Sales Q/Q
6.17%
Insider Own
0.16%
Insider Trans
-62.77%
Inst Own
89.60%
Inst Trans
-0.87%
ROA
1.15%
ROE
3.80%
ROIC
1.94%
Gross Margin
13.88%
Oper. Margin
3.26%
Profit Margin
0.72%
SMA20
-5.77%
SMA50
-2.05%
SMA200
17.39%
Trades
Shs Outstand
1.28B
Shs Float
1.27B
52W High
110.68 -9.85%
52W Low
62.52 59.60%
Volatility
2.88% 2.55%
ATR (14)
2.88
RSI (14)
39.06
Beta
0.58
Rel Volume
0.00
Avg Volume
8.49M
Volume
862
Perf Week
-5.17%
Perf Month
-4.49%
Perf Quarter
14.87%
Perf Half Y
32.62%
Perf YTD
25.73%
Perf Year
57.08%
Perf 3Y
36.89%
Perf 5Y
22.81%
Perf 10Y
2.48%
Prev Close
99.12
Price
99.78
Change
0.67%
Date Action Analyst Rating Change Price Target Change
Mar-12-26Upgrade Bernstein Mkt Perform → Outperform $94
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Aug-05-26 05:10PM
04:30PM
03:04PM
02:36PM
12:45PM
11:50AM Loading…
11:50AM
11:02AM
10:53AM
09:54AM
09:41AM
08:03AM
07:53AM
07:15AM
07:11AM
06:39AM
06:38AM Loading…
06:38AM
06:30AM
06:25AM
Aug-04-26 04:32PM
09:00AM
Aug-03-26 04:17PM
09:31AM
Jul-31-26 10:36AM
Jul-30-26 05:38PM
01:50PM
01:02PM
09:00AM
Jul-29-26 11:36AM
11:06AM
09:00AM
05:30AM Loading…
05:30AM
Jul-28-26 05:41PM
Jul-27-26 05:24AM
Jul-24-26 04:56PM
Jul-22-26 09:00AM
Jul-21-26 11:07PM
05:26PM
04:33PM
09:00AM
Jul-20-26 12:56PM
10:43AM
Jul-17-26 06:09PM
06:02PM
02:00PM
12:00PM
08:25AM
Jul-16-26 04:24PM
10:54AM
09:19AM
08:58AM
08:30AM
08:30AM
08:00AM
Jul-15-26 08:30AM
07:21AM
Jul-14-26 08:00PM
04:47PM
03:05PM
11:10AM
Jul-13-26 01:54PM
03:00AM
Jul-10-26 09:48AM
07:55AM
05:32AM
04:50AM
Jul-09-26 10:08AM
09:47AM
09:24AM
Jul-08-26 02:24PM
Jul-06-26 12:11PM
09:00AM
Jul-03-26 08:20AM
Jul-01-26 05:19AM
Jun-30-26 10:52AM
Jun-26-26 06:10AM
Jun-25-26 10:08AM
09:40AM
09:00AM
09:00AM
Jun-24-26 11:35AM
08:35AM
08:09AM
07:01AM
Jun-23-26 06:01PM
05:33PM
Jun-22-26 08:00AM
Jun-18-26 01:59PM
Jun-17-26 05:30AM
Jun-16-26 11:44AM
07:23AM
Jun-12-26 12:36PM
Jun-10-26 03:39PM
09:00AM
Jun-09-26 06:41AM
Jun-07-26 07:35PM
Jun-05-26 04:35PM
04:20PM
Jun-04-26 12:38PM
May-29-26 10:22AM
08:00AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CEOMr. J. David Joyner CEBS
Executive VP & CFOMr. Brian O. Newman
EVP of Ventures and Chief Experience & Technology OfficerMr. Tilak Mandadi
Executive VP & Group PresidentMr. Prem S. Shah Pharm.D
Executive VP & President of AetnaMr. Steven Hale Nelson M.B.A.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AGUIRRE FERNANDODirectorMay 20 '26Proposed Sale94.692,263214,283May 22 05:35 PM
ROBBINS LARRYDirectorMay 19 '26Sale94.451,983,538187,341,3086,213,261May 21 05:43 PM
ROBBINS LARRYDirectorMay 20 '26Sale93.821,018,00095,510,8225,195,261May 21 05:43 PM
ROBBINS LARRYDirectorMay 21 '26Sale93.45370,46234,619,0074,824,799May 21 05:43 PM
FARAH ROGER NDirectorMay 21 '26Proposed Sale93.682,817263,886May 21 12:57 PM
Mandadi TilakEVP, Chief Exp & Tech OfficerMay 08 '26Sale89.5869,5516,230,37910,133May 11 05:27 PM
TILAK MANDADIOfficerMay 08 '26Proposed Sale89.5869,5516,230,719May 08 04:36 PM
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM